These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 31754336)

  • 1. Evaluation of the effects of sequence length and microsatellite instability on single-guide RNA activity and specificity.
    Zhao C; Wang Y; Nie X; Han X; Liu H; Li G; Yang G; Ruan J; Ma Y; Li X; Cheng H; Zhao S; Fang Y; Xie S
    Int J Biol Sci; 2019; 15(12):2641-2653. PubMed ID: 31754336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
    Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
    PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of CRISPR/Cas9 sgRNA Design Tools.
    Cui Y; Xu J; Cheng M; Liao X; Peng S
    Interdiscip Sci; 2018 Jun; 10(2):455-465. PubMed ID: 29644494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refined sgRNA efficacy prediction improves large- and small-scale CRISPR-Cas9 applications.
    Labuhn M; Adams FF; Ng M; Knoess S; Schambach A; Charpentier EM; Schwarzer A; Mateo JL; Klusmann JH; Heckl D
    Nucleic Acids Res; 2018 Feb; 46(3):1375-1385. PubMed ID: 29267886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
    Hiranniramol K; Chen Y; Liu W; Wang X
    Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome analysis of CRISPR Cas9 sgRNA off-target homologies via an efficient computational algorithm.
    Zhou H; Zhou M; Li D; Manthey J; Lioutikova E; Wang H; Zeng X
    BMC Genomics; 2017 Nov; 18(Suppl 9):826. PubMed ID: 29219081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
    Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
    Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vectors for simple and streamlined CRISPR-Cas9 genome editing in Saccharomyces cerevisiae.
    Laughery MF; Hunter T; Brown A; Hoopes J; Ostbye T; Shumaker T; Wyrick JJ
    Yeast; 2015 Dec; 32(12):711-20. PubMed ID: 26305040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR multitargeter: a web tool to find common and unique CRISPR single guide RNA targets in a set of similar sequences.
    Prykhozhij SV; Rajan V; Gaston D; Berman JN
    PLoS One; 2015; 10(3):e0119372. PubMed ID: 25742428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Silico Meets In Vivo: Towards Computational CRISPR-Based sgRNA Design.
    Chuai GH; Wang QL; Liu Q
    Trends Biotechnol; 2017 Jan; 35(1):12-21. PubMed ID: 27418421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In silico CRISPR-based sgRNA design].
    Wang Y; Chuai G; Yan J; Shi L; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1744-1756. PubMed ID: 29082722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CRISPR/CAS9, the King of Genome Editing Tools].
    Bannikov AV; Lavrov AV
    Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Tools and Resources for CRISPR/Cas Genome Editing.
    Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
    Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.
    Wang Z; Wang W; Cui YC; Pan Q; Zhu W; Gendron P; Guo F; Cen S; Witcher M; Liang C
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30068653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential high-frequency off-target mutagenesis induced by CRISPR/Cas9 in Arabidopsis and its prevention.
    Zhang Q; Xing HL; Wang ZP; Zhang HY; Yang F; Wang XC; Chen QJ
    Plant Mol Biol; 2018 Mar; 96(4-5):445-456. PubMed ID: 29476306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3'-terminal segment of guide RNA.
    Mekler V; Minakhin L; Semenova E; Kuznedelov K; Severinov K
    Nucleic Acids Res; 2016 Apr; 44(6):2837-45. PubMed ID: 26945042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized CRISPR/Cas9 system for gene knockout in chicken DF1 cells.
    Zou K; Wang F; Zhang Z; Zhou Y; Li P; Wang D; Zhu M; Jia C; Wei Z
    Poult Sci; 2023 Oct; 102(10):102970. PubMed ID: 37562129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.